Skip to main content

Table 1 Distribution of maternal and obstetric characteristics among all singleton pregnancies resulting in livebirth in Sweden, by exposure to proton pump inhibitors (PPIs)

From: Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events

 

Total

PPI users

PPI non-users

 

N

%

N

%

N

%

Total

1,089,515

100.00%

14,787

1.40%

1,074,728

98.60%

Maternal age (years) at delivery

 ≤ 25

206,620

19.00%

2123

14.40%

204,497

19.00%

25–30

353,028

32.40%

4321

29.20%

348,707

32.40%

30–35

347,795

31.90%

4850

32.80%

342,945

31.90%

 > 35

182,072

16.70%

3493

23.60%

178,579

16.60%

Body mass index(kg/m2) at enrolment

 < 20

105,145

9.70%

1122

7.60%

104,023

9.70%

20–25

526,129

48.30%

5548

37.50%

520,581

48.40%

25–30

256,024

23.50%

3957

26.80%

252,067

23.50%

 ≥ 30

129,030

11.80%

3190

21.60%

125,840

11.70%

Missing

73,187

6.70%

970

6.60%

72,217

6.70%

Tobacco consumption

Yes

75,600

6.90%

1335

9.00%

74,265

6.90%

No

1,013,915

93.10%

13,452

91.00%

1,000,463

93.10%

Comorbidities*

Yes

64,076

5.90%

1755

11.90%

62,321

5.80%

No

1,025,439

94.10%

13,032

88.10%

1,012,407

94.20%

Exposure to H2 receptor antagonists

Yes

2321

0.20%

320

2.20%

2001

0.20%

No

1,087,194

99.80%

14,467

97.80%

1,072,727

99.80%

Exposure to other drugs**

Yes

349,252

32.10%

7929

53.60%

341,323

31.80%

No

740,263

67.90%

6858

46.40%

733,405

68.20%

Assisted reproduction

Yes

31,799

2.90%

574

3.90%

31,225

2.90%

No

1,057,716

97.10%

14,213

96.10%

1,043,503

97.10%

Mode of delivery

Vaginal

906,006

83.20%

11,275

76.20%

894,731

83.30%

Cesarean section

183,509

16.80%

3512

23.80%

179,997

16.70%

Parity

1

481,573

44.20%

6140

41.50%

475,433

44.20%

2

400,762

36.80%

4607

31.20%

396,155

36.90%

 ≥ 3

207,180

19.00%

4040

27.30%

203,140

18.90%

Time interval between pregnancies (months)

 < 18

141,036

12.90%

1751

11.80%

139,285

13.00%

18–23

63,910

5.90%

737

5.00%

63,173

5.90%

 > 23

164,468

15.10%

2676

18.10%

161,792

15.10%

0

720,101

66.10%

9623

65.10%

710,478

66.10%

  1. *Comorbidities defined as at least one diagnosis of hypertension, diabetes mellitus, and hypo- or hyperthyroidism
  2. **Other drugs defined as at least one prescription of non-steroid anti-inflammatory drugs (NSAIDs), low-dose aspirin, or antibiotics 3 months before or during gestation